🔗 Permalink

Inventor profile of:

Wei Kong

City:

Phoenix, Arizona

Country:

United States

Published Applications:

Last publication date:

2023-10-26

Top Assignees for applications by Wei Kong

The entities that hold a legal rights for patent applications filed by inventor Kong Wei:

THE WASHINGTON UNIVERSITY 6 St. Louis, MO United States
The Arizona Board of Regents For and On Behalf Of Arizona State University 4 Tempe, AZ United States
THE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY 4 Scottsdale, AZ United States
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 3 Scottsdale, AZ United States
Arizona Board of Regents for and on Behalf of Arizona State University 1 Tempe, AZ United States
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 1 Tempe, AZ United States
Arizona Broad of Regents on Behalf of Arizona State University 1 Scottsdale, AZ United States

Recent patent applications by Kong Wei

Wei Kong from Phoenix, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-10-26

US20230338436A1

Human necessities

TUMOR-DELIVERED MULTI-TARGET THERAPEUTICS FOR COLON CANCER

#2 | 2022-05-12

US20220143105A1

Human necessities

Tumor-delivered multi-target therapeutics for colon cancer

#3 | 2022-03-24

US20220090097A1

Chemistry; metallurgy

Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

#4 | 2022-02-10

US20220042046A1

Chemistry; metallurgy

Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy

#5 | 2021-12-16

US20210386795A1

Human necessities

Using tumor-navigating to modulate tumor metabolism

#6 | 2020-12-03

US20200377897A1

Chemistry; metallurgy

Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

#7 | 2020-05-28

US20200165620A1

Chemistry; metallurgy

Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

#8 | 2018-11-08

US20180320189A1

Chemistry; metallurgy

REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY

#9 | 2017-10-26

US20170306338A1

Chemistry; metallurgy

RECOMBINANT BACTERIUM TO DECREASE TUMOR GROWTH

#10 | 2017-08-10

US20170224806A1

Human necessities

RECOMBINANT BACTERIUM AND METHODS OF ANTIGEN AND NUCLEIC ACID DELIVERY

#11 | 2016-07-14

US20160199467A1

Human necessities

Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

#12 | 2013-08-15

US20130209405A1

Chemistry; metallurgy

Recombinant bacterium to decrease tumor growth

#13 | 2013-07-04

US20130171190A1

Chemistry; metallurgy

Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety

#14 | 2012-04-12

US20120087946A1

Human necessities

Recombinant bacterium and methods of antigen and nucleic acid delivery

#15 | 2010-05-20

US20100124558A1

Chemistry; metallurgy

Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety

#16 | 2006-06-29

US20060140975A1

Chemistry; metallurgy

Regulated bacterial lysis for gene vaccine vector delivery and antigen release

InventorID:

323407 ⎘